- Press Releases
TYSONS CORNER, VA, Oct. 10, 2016 Engility (NYSE: EGL) will conduct clinical trials to test the efficacy of experimental Chikungunya virus vaccines under a five-year, $10 million task order from the Walter Reed Army Institute of Research, ExecutiveBiz reported Friday. The company said Thursday the new work comes under the potent...


